|
|
|
||||||||||
Professor of Internal Medicine Université Louis Pasteur Strasbourg, France Clinical Specialist Department of Internal Medicine, Diabetes and Metabolic Disorders Clinique Médicale B Hôpitaux Universitaires de Strasbourg 1 Place de l'Hôpital 67 091 Strasbourg cedex, France FAX 33-3-88-11-62-62 emmanuel.andres{at}chru-strasbourg.fr
Assistant of Internal Medicine Université Louis Pasteur Clinical Specialist Department of Internal Medicine, Diabetes and Metabolic Disorders Hôpitaux Universitaires de Strasbourg
Assistant of Internal Medicine Université Louis Pasteur Clinical Specialist Department of Internal Medicine, Diabetes and Metabolic Disorders Hôpitaux Universitaires de Strasbourg
Published Online, September 18, 2003. www.theannals.com, DOI 10.1345/aph.1D189
Case Reports. The median age of the patients was 70 years (range 49-76); the male/female ratio was 4/2. The mean duration of the acid-suppressive drug administration (omeprazole [n = 3], ranitidine [n = 1], cimetidine [n = 1], sodium bicarbonate [n = 1]) was 7.1 years (range 5.5-9). Clinical features included peripheral neuropathy in 1 patient. Blood count abnormalities included mild anemia (hemoglobin [Hb] <10 g/dL) in 2 patients. The mean ± SD Hb level was 10.9 ± 2.4 g/dL (range 8-12.8) and the mean erythrocyte cell volume was 96 ± 8 fL (range 87-102). The mean serum B12 (normal >200 pg/mL) and total homocysteine levels (normal >13 µmol/L) were 118 ± 37 pg/mL (range 70-162) and 13 ± 2.3 µmol/L (range 11-20), respectively.
All patients had normal serum folate and creatinine levels; none had antiintrinsic factor antiparietal cell antibodies. All patients had normal Schilling's test results (Dicopac test, Amersham, Birmingham, UK). No patient had a nutritional B12 deficiency. One patient with anemia was successfully treated with oral crystalline cyanocobalamin 2000 µg/wk despite continuous administration of an acid-suppressive drug. Other patients had been treated with intramuscular cyanocobalamin (n = 4). In all cases, correction of the serum B12 levels and blood count abnormalities occurred during the first 6 months of treatment.
Discussion. Acid-suppressive drugs represent about 4% of the etiologies in this population, and are undoubtedly the principal causative drugs (with metformin) of B12 deficiency in adults.3,5 The B12 deficiency related to long-term acid suppression therapy is mild ("subtle cobalamin deficiency"),5 with no or only mild clinical and hematologic abnormalities.2,3 As several authors have previously reported,1,2 our data suggest that the principal mechanism of B12 deficiency related to long-term acid suppression therapy is food-cobalamin malabsorption (FCM). This syndrome is characterized by the inability to release B12 from food or its binding protein.3,5 Thus, patients have low serum B12 levels, normal Schilling's test results, and commonly hypochlorhydria.
The partial nature of this form of malabsorption produces a more slowly progressing depletion of B12 than does the more complete malabsorption engendered by disruption of intrinsic factor-mediated absorption. This partial malabsorption also explains why subtle cobalamin deficiency is often associated with FCM.5 This mechanism of partial FCM may explain the potential efficacy of oral crystalline cyanocobalamin.3,5 In our opinion, acid-suppressive drugs may often be continued with appropriate B12 supplementation.
Physicians should always reassess patients who are taking acid-suppressive drugs for a long time for vitamin B12 status because of potentially irreversible neurologic complications.
References
This article has been cited by other articles:
![]() |
N. Dali-Youcef and E. Andres An update on cobalamin deficiency in adults QJM, January 1, 2009; 102(1): 17 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Andres, N. H. Loukili, E. Noel, G. Kaltenbach, M. B. Abdelgheni, A. E. Perrin, M. Noblet-Dick, F. Maloisel, J.-L. Schlienger, and J.-F. Blickle Vitamin B12 (cobalamin) deficiency in elderly patients Can. Med. Assoc. J., August 3, 2004; 171(3): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||